• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Morphochem - Articles and news items

IV C difficile treatment

FDA grants QIDP for C. Difficile IV treatment

Industry news / 25 July 2016 / Niamh Louise Marriott, Digital Content Producer

Morphochem announced today that the U.S. FDA has designated Morphochem’s intravenous antibacterial product as a Qualified Infectious Disease Product…

 

Webinar: Use of MicroNIR to optimise fluid bed drying and to reduce waste at tablet compressionFIND OUT MORE
+ +